Bryn Mawr Capital Management Inc’s Elevance Health ELV Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-14,220	Closed	-$1.99M	–	93
2015 Q3	$1.99M	Buy	+14,220	New	+$2.14M	0.35%	92
2015 Q2	–	Sell	-20,000	Closed	-$3.09M	–	487
2015 Q1	$3.09M	Sell	20,000 -10,112	-34%	-$1.44M	0.41%	84
2014 Q4	$3.78M	Buy	+30,112	New	+$3.72M	0.48%	70
2014 Q1	–	Sell	-5,109	Closed	-$472K	–	570
2013 Q4	$472K	Sell	5,109 -20,178	-80%	-$1.79M	0.03%	362
2013 Q3	$2.11M	Buy	+25,287	New	+$2.17M	0.14%	180

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Bryn Mawr Capital Management Inc's ELV Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of Elevance Health (ELV) in Q4 2015, closing a stake of 14,220 shares — an estimated $1.99M sold.

Bryn Mawr Capital Management Inc first reported a position in ELV in Q3 2013 and held it in 5 quarters. The position peaked at $3.78M in Q4 2014. 765 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Bryn Mawr Capital Management Inc reported no remaining Elevance Health position as of Q4 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 14,220 Elevance Health shares in Q4 2015, an estimated $1.99M.
Bryn Mawr Capital Management Inc first reported a position in Elevance Health in Q3 2013 and held it in 5 quarters.
Bryn Mawr Capital Management Inc's Elevance Health position peaked at $3.78M in Q4 2014.
765 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.